H. F. BATIREL Et Al. , "Long-term (2 years) malignant pleural mesothelioma survivors following chemotherapy and multimodality treatment have similar features and survival outcomes," International Conference of the International Mesothelioma Interest Group , 2012
BATIREL, H. F. Et Al. 2012. Long-term (2 years) malignant pleural mesothelioma survivors following chemotherapy and multimodality treatment have similar features and survival outcomes. International Conference of the International Mesothelioma Interest Group .
BATIREL, H. F., AK, G., METİNTAŞ, M., ERMERAK, N. O., YUMUK, P. F., ÖZKÖK, H. B., ... KARA, V.(2012). Long-term (2 years) malignant pleural mesothelioma survivors following chemotherapy and multimodality treatment have similar features and survival outcomes . International Conference of the International Mesothelioma Interest Group
BATIREL, HASAN Et Al. "Long-term (2 years) malignant pleural mesothelioma survivors following chemotherapy and multimodality treatment have similar features and survival outcomes," International Conference of the International Mesothelioma Interest Group, 2012
BATIREL, HASAN F. Et Al. "Long-term (2 years) malignant pleural mesothelioma survivors following chemotherapy and multimodality treatment have similar features and survival outcomes." International Conference of the International Mesothelioma Interest Group , 2012
BATIREL, H. F. Et Al. (2012) . "Long-term (2 years) malignant pleural mesothelioma survivors following chemotherapy and multimodality treatment have similar features and survival outcomes." International Conference of the International Mesothelioma Interest Group .
@conferencepaper{conferencepaper, author={HASAN FEVZİ BATIREL Et Al. }, title={Long-term (2 years) malignant pleural mesothelioma survivors following chemotherapy and multimodality treatment have similar features and survival outcomes}, congress name={International Conference of the International Mesothelioma Interest Group}, city={}, country={}, year={2012}}